Drug Discovery and Delivery

A vaccine strategy involving formulation changes, an initial escalating dose, and a longer wait for booster immunization results in more-effective antibody production against HIV in rhesus monkeys, a study finds.

Dr. Xinxin Ding, a professor and head of the Department of Pharmacology and Toxicology at the UArizona R. Ken Coit College of Pharmacy, was elected secretary/treasurer of the American Society for Pharmacology and Experimental Therapeutics (ASPET) council.

The annual event exploring groundbreaking approaches in drug discovery is making an in-person return to Phoenix in September.

Researchers at the Center for Innovation in Brain Science are flipping the traditional research model by first considering known factors underlying diseases and then seeking treatments using technologies to scan data for patterns that suggest certain compounds may impact those biological pathways.

Summer programs through the UArizona Health Sciences Office of Equity, Diversity and Inclusion focus on fostering diversity in health professions and setting students up for graduate and medical school success. Two students, Emma Gallardo Martinez and Tawanda Zvavamwe, provided a glimpse into their 10-week experiences.

The American Association of Colleges of Pharmacy ranked the R. Ken Coit College of Pharmacy fifth in the nation by National Institutes of Health funding based on grants awarded to principal investigators in U.S. colleges and schools of pharmacy.

Dr. Rick Schnellmann, dean of the R. Ken Coit College of Pharmacy, received the 2022 Robert W. Berliner Award for Excellence in Renal Physiology from the American Physiological Society (APS).

UArizona has licensed the new class of drugs designed to penetrate the blood-brain barrier that could be used to treat degenerative neurological diseases and conditions to startup Teleport Pharmaceuticals and inventor Dr. Robin Polt.

One Health is the overlap between human, animal, and environmental health and UArizona researchers are collaborating to understand the intersection of different science to improve health outcomes.

Researchers at two state universities are joining forces to battle the opioid epidemic with help from decades of chemistry research conducted by Purdue Pharma.